News

  • Martis Capital
  • No Comments

Martis Capital Announces Two Investment Team Promotions
Martis Capital Announces Two Investment Team Promotions 150 150 Martis Capital

Martis Capital, a middle-market private equity firm focused exclusively on the healthcare industry, is pleased to kick off 2024 with two investment team promotions. Aseem Nambiar has been promoted from Director to Principal, and David Zhang from Vice President to Director.

Based in San Francisco, CA, Aseem joined Martis in 2019 and helps lead the firm’s investments in DCN Dx, Lighthouse Lab Services and WellHaven PetHealth. Prior to Martis, he held an operating role at DaVita, following his time at Waud Capital and UBS. Aseem received a Bachelor of Science in Quantitative Economics from Tufts University and an MBA from the University of Pennsylvania.

Based in San Francisco, CA, David joined Martis in 2020 and helps lead the firm’s investments in Alcanza Clinical Research, Lighthouse Lab Services and Rise Health. He started his career at Barclays, then focused on middle-market buyout investing at Welsh, Carson, Anderson & Stowe and Calera Capital. David received a Bachelor in Business Administration from the Stephen M. Ross School of Business at the University of Michigan.

“With the final closing of Fund IV and active deal activity across new platforms and add-ons, the past twelve months have marked a period of continued strong growth for Martis Capital. As we head into the new year, we’re thrilled to recognize Aseem’s and David’s contributions to the firm, as well as their professional growth and achievement,” said Founding & Managing Partner, Barry Uphoff.

About Martis Capital

Based in Washington, DC and San Francisco, Martis Capital is a founder-friendly capital partner for growth-oriented healthcare companies. Since 2011, Martis Capital has raised more than $2.2 billion from a global base of institutional clients to invest in the middle-market North American healthcare sector. For more information, visit www.martiscapital.com.

  • Martis Capital
  • No Comments

Martis Capital Named to Inc.’s Founder-Friendly Investors List for Third Consecutive Year
Martis Capital Named to Inc.’s Founder-Friendly Investors List for Third Consecutive Year 448 486 Martis Capital

WASHINGTON and SAN FRANCISCO, Oct. 31, 2023 – For the third consecutive year, Martis Capital Management, LLC (Martis Capital), a healthcare-focused private equity firm, has been named to Inc. magazine’s Founder-Friendly Investors list, recognizing the private equity and venture capital firms with the best track records of success backing entrepreneurs.

Introduced in 2019, the Inc. Founder-Friendly Investors list is considered the go-to guide for entrepreneurs who want to grow their companies while retaining a meaningful ownership stake. As part of the evaluation process, Inc. interviewed founders to learn about their experiences and collected data on how their companies have grown as a result of these partnerships. Of the 218 firms honored, Martis Capital was one of eight healthcare-exclusive private equity firms listed and one of only three healthcare-exclusive firms to be recognized for a third consecutive year.

“This industry acknowledgment is particularly rewarding to us because it honors the importance of partnerships between founders, their teams and their investors,” said Owen Davis, managing partner of Martis Capital.

“We envision a new era in U.S. healthcare defined by better patient outcomes through value-based care and data-driven decision support,” said Justin Dangel, chairman of Martis portfolio company Rise Health.  “Martis’ experience and its transparent, collaborative and partnership mentality have enabled us to execute on our shared vision.”

“Inc. magazine is devoted to providing entrepreneurs with all the tools and resources they need to start, run, grow, and sometimes exit their businesses,” said Scott Omelianuk, editor-in-chief of Inc. media. “The 2023 Founder-Friendly Investors list is our way of guiding entrepreneurs to proven partners they can trust and collaborate with while receiving the financial support they need to accelerate growth.”

To see the complete list of Inc.’s Founder-Friendly Investors, visit https://www.inc.com/founder-friendly-investors/2023

About Martis Capital

Based in Washington, DC and San Francisco, Martis Capital is a founder-friendly capital partner for growth-oriented healthcare companies. Since 2011, Martis Capital has raised more than $2.2 billion from a global base of institutional clients to invest in the middle-market North American healthcare sector. For more information, visit www.martiscapital.com.

Media Contacts

Newton Park PR, LLC

Margaret Kirch Cohen
+1 847 507 2229
margaret@newtonparkpr.com

Richard Chimberg
+1 617 312 4281
rich@newtonparkpr.com

  • Martis Capital
  • No Comments

WellHaven PetHealth Expands to Arizona, adding Blue Cross Veterinary Clinic
WellHaven PetHealth Expands to Arizona, adding Blue Cross Veterinary Clinic 448 486 Martis Capital

In October 2023, WellHaven PetHealth acquired Blue Cross Veterinary Clinic in Arizona, marking partnerships in six active markets for WellHaven. “We are thrilled to welcome the Blue Cross Veterinary Clinic to the WellHaven family,” shared CEO, Jenni Jones. “We are thankful for the compassionate care they provide and look forward to helping them continue their mission of providing quality pet care.”

“It’s been a privilege to work with Jenni Jones and the WellHaven team to continue our de novo and acquisition strategy as we expand across the U.S.” commented Martis Capital Managing Partner, Owen Davis.

About WellHaven

Founded in 2017, WellHaven PetHealth was started by Martis as a multi-regional platform of veterinary practices providing a full range of veterinary services including internal medicine, emergency medicine, surgery, oncology, dentistry, dermatology, grooming, boarding, pharmacy, laboratory, and radiology services. WellHaven now has more than 40 hospitals across Colorado, Minnesota, Washington, Oregon, Montana and Arizona.

  • Martis Capital
  • No Comments

Chris Beall Promoted to Partner at Martis Capital
Chris Beall Promoted to Partner at Martis Capital 448 486 Martis Capital

Martis Capital, a middle-market private equity firm focused exclusively on the healthcare industry, announced that Chris Beall has been promoted to Partner.

During his tenure at Martis, Chris has been an active contributor, closing five platforms as well as leading the firm’s most recent investment in Dental Associates of Connecticut (DACT).  Chris was also instrumental in the successful exits of HHA eXchange, Altruista Health, and Care Hospice.  He currently serves on the Board of Directors of Qualifacts, Community Based Care, and DACT.

Prior to joining Martis in 2014, Chris was an Associate at Quad-C Management and previously worked in investment banking in the Retail & Consumer Group at Citi.  He received a BS in Commerce from the McIntire School of Commerce at the University of Virginia.

“It’s been rewarding to see Chris grow and develop during his time at Martis, and we are very excited to now have him as a Partner in the firm leading investments and helping to manage portfolio companies alongside us,” said Founder and Managing Partner, Barry Uphoff.

Based in Washington, DC and San Francisco, Martis Capital is a founder-friendly capital partner for growth-oriented healthcare companies. Since 2011, Martis Capital has raised more than $2.2 billion from a global base of institutional clients to invest in the middle-market North American healthcare sector. For more information, visit www.martiscapital.com.

  • Martis Capital
  • No Comments

Alcanza Expands Network Size and Patient Reach with Acquisition of Accel Research Sites
Alcanza Expands Network Size and Patient Reach with Acquisition of Accel Research Sites 448 486 Martis Capital

Alcanza Clinical Research announces the acquisition of Accel Research Sites Network, a multi-specialty network headquartered in Florida, with additional sites in Alabama and Georgia. As a leader in medical research since 1998, Accel’s network of 22 sites includes eight clinical research units and 14 embedded sites strategically placed in healthcare settings across the Southeast U.S.

“The addition of Accel to the Alcanza network is part of our strategy to operate with greater scale and therapeutic specialization to reach more patient populations who are not traditionally presented with research participation opportunities,” said Carlos Orantes, CEO of Alcanza. “Accel’s breadth of therapeutic expertise, reputation for on-time enrollment and their access to diverse patient populations are a perfect complement for Alcanza’s growth portfolio.”

“We are looking for a partner with aligned vision to further our mission of patient-centric clinical research while reducing barriers to participation,” said Dr. Lora Parahovnik, CEO of Accel. “That partner is Alcanza. This move will enable us to conduct clinical trials more efficiently, effectively, and inclusively than ever before. Together, we’ll be able to offer more opportunities for patients to participate in clinical research, and we’ll be better positioned to recruit and retain high-quality research staff.”

Accel’s site operations will be integrated into Alcanza’s centralized platform while retaining its name and brand identity.

About Alcanza Clinical Research

Alcanza Clinical Research is an integrated network of research facilities focused on bringing clinical trial opportunities involving life-changing treatments and vaccines to all patients, especially those from under-represented communities. With locations in Alabama, Florida, Georgia, Massachusetts, Michigan, New Hampshire, South Carolina, and Virginia, we specialize in a range of conditions across allergy, cardiology, dermatology, endocrinology, immunology, infectious disease, neurology, ophthalmology, psychiatry, and respiratory therapeutic areas.

  • Martis Capital
  • No Comments

Martis Capital Closes Oversubscribed Fourth Fund at $779 Million
Martis Capital Closes Oversubscribed Fourth Fund at $779 Million 448 486 Martis Capital

Martis Capital Management, LLC (Martis Capital), a healthcare-focused private equity firm, has closed its fourth fund, Martis Partners IV, LP (Fund IV), with $779 million in capital commitments, exceeding its target of $700 million.

Fund IV’s commitments come from a diverse group of existing and new individual and institutional investors globally. With the new fund, Martis Capital has raised more than $2.1 billion in capital to date.

“We are grateful for the ongoing and enthusiastic support from our existing and new investors,” said Barry Uphoff, founder and managing partner at Martis Capital.

Martis Capital invests in buyout and growth equity opportunities in middle-market companies providing innovative and cost-effective products and services within the services and outsourcing, information technology, and consumer and wellness subsectors of the North American healthcare industry.

“Our team continues to execute on our consistent strategy, and we are well positioned to deploy capital within our growth targets,” said Mario Moreno, managing partner.

The firm has made three investments from Fund IV in companies specializing in clinical research trials, value-based primary care, and comprehensive dental care.

“Fund IV, our largest to date, is off to a great start. Our three initial investments are performing well, a testament to the quality of our partner companies and the research and due diligence of the Martis Capital team,” said Owen Davis, managing partner.

Martis Capital is the only dedicated healthcare PE firm to receive both Grady Campbell’s Top 50 PE Firms Award and Inc. Magazine’s Founder-Friendly Investors Award in 2022 and 2021. The firm is also among GrowthCap’s Top 25 Healthcare Investors of 2023.

Metric Point Capital was the primary placement agent, and McDermott Will & Emery LLP served as legal counsel.

About Martis Capital

Based in San Francisco and Washington, DC, Martis Capital is a founder-friendly capital partner for growth-oriented healthcare companies. Since 2011, Martis Capital has raised more than $2.1 billion from a global base of institutional clients to invest in the middle-market North American healthcare sector. For more information, visit www.martiscapital.com.

  • Martis Capital
  • No Comments

Martis Capital Recognized for Contributions to Clinical Trials Market
Martis Capital Recognized for Contributions to Clinical Trials Market 150 150 Martis Capital
  • Martis Capital
  • No Comments

Martis Capital recognized as a Top 50 PE firm in the Middle Market for third consecutive year
Martis Capital recognized as a Top 50 PE firm in the Middle Market for third consecutive year 448 486 Martis Capital

 

Martis Capital is excited to have been named a Top 50 PE Firm in the Middle Market for the third consecutive year. Top PE Firms in the Middle Market™ is the oldest and most highly regarded award program, and we are honored to receive this nomination as a reflection of our deep industry expertise and thoughtful investment approach.

Martis was one of just three healthcare exclusive private equity firms to receive this award in 2023, and the only healthcare exclusive firm recognized for more than one year in a row.

Martis did not pay a fee as part of the selection process.  To read more about the Top 50 PE program and view a detailed list of winning firms, please visit TOP 50 PE Firms — GCI Publishing.

  • Martis Capital
  • No Comments

Martis Capital Announces Recent Promotions
Martis Capital Announces Recent Promotions 150 150 Martis Capital

Martis Capital is pleased to announce two recent team promotions. Vladimir Andonov has been promoted from Director of Business Development to Managing Director of Business Development, and Phil Campbell from Vice President to Director.

Based in San Francisco, CA, Vladimir has worked at Martis Capital since the firm’s inception. Over the last four years, he has primarily led Martis’ formal business development efforts, in addition to playing an active role with the firm’s investor base.  Vladimir previously worked at Capricorn Investment Group and J.P. Morgan. He received a BA in Economics and Political Science from Williams College and an MBA from the University of Chicago, and is a CFA charterholder.

Based in Washington, DC, Phil joined Martis in 2016 and has worked closely with a number of the firm’s portfolio companies, including Community Based Care, ShareMD, CitizensRx, Synergy Health Partners, Care Hospice, and Centria Healthcare.  Prior to Martis, he worked at CIT Group and HJ Sims, with a focus on healthcare. Phil received a BS in Finance & Accounting from the Carroll School of Management at Boston College.

“We’re excited to announce the promotions of Vladimir Andonov and Phil Campbell”, said Barry Uphoff, Founding Partner of Martis Capital. “Their contributions within Martis and their support across our portfolio companies have been critical to our firm’s success. Please join us in congratulating these two on these well-deserved achievements.”

About Martis Capital

Martis Capital is a private equity firm focused exclusively on the healthcare industry. With offices in San Francisco, CA, and Washington, DC, Martis seeks to invest in middle-market, growth-oriented companies that provide innovative and cost-effective products and services within targeted segments of the North American healthcare industry.

For more information, please visit www.martiscapital.com or follow us on LinkedIn.

  • Martis Capital
  • No Comments

Martis Capital and Lorient Capital Launch Rise Health
Martis Capital and Lorient Capital Launch Rise Health 150 150 Martis Capital

Rise Health logo

Phoenix, AZ, December 19, 2022  ̶   Rise Health, a primary care platform that leverages technology to operate and support value-based primary care clinics, today announced the closing of a growth equity investment by Lorient Capital and Martis Capital to support continued market expansion.

Rise Health was founded to accelerate the adoption of value-based primary care to support primary care physicians in helping their patients get the best care possible. Rise Health provides its primary care practices with access to premium care delivery models and top-tier specialists to reduce practitioner administrative burden so they can focus on providing high-quality, evidence-based care for their patients. The technology-enabled model allows Rise Health to focus on outcomes and quality of care over volume of services with a focus on serving underserved patient populations.

“We co-founded Rise Health because we believe that primary care physicians know best how to care for their patients. Our value-based model aligns the business of primary care with the best interest of patients,” said Justin Dangel, Rise Health co-founder and chairman and partner at Despierta. “We could not be more excited to partner with two world-class firms who share our vision for the future of primary care: Lorient and Martis Capital.”

“We are excited to partner with an innovative and experienced management team at Rise Health that have spent their careers dedicated to clinical and operation excellence,” said Jordan Broome, Managing Partner at Lorient Capital. “We have a shared vision to usher in the next generation of value-based care that is focused on partnering with primary care practices to help them evolve into the linchpin and quarterback of the care continuum they were always meant to be.”

“This is an opportunity to partner with a unique value-based platform focused on driving reductions in healthcare cost while providing high-quality patient care,” said Barry Uphoff, Founding / Managing Partner at Martis Capital. “The Rise team has a clear vision for how their differentiated approach and technology infrastructure can address this longstanding challenge.”

The partnership will allow Rise Health to accelerate growth across the Southwest United States, with a focus on partnering with providers who are interested in eliminating unnecessary spending and improving the quality of care for their patients. Rise Health will continue to invest in technology to lower the cost curve and meet the needs of its growing patient population.

“We founded Rise Health because we believe that everyone should have access to high-quality healthcare, and that empowering primary care clinicians with the tools, technology and data to lead the transformation to value-based care is the best way to break down the barriers for traditionally underserved neighborhoods,” said Keith Pinter, CEO and co-founder of Rise Health. “The team we have built to date, including Dr. Mike Phillips as our Chief Medical Officer and Dr. Srinivas Bollimpalli as our Chief Operations Officer, is taking the best of what they have seen in healthcare today and bringing it together to deliver a fundamentally different model to the people who need it most. The partnership announced today is a testament to the confidence we have in the future impact Rise will make on the industry and for our patients.”

 

About Rise Health
Founded in 2021 by Keith Pinter, Justin Dangel, Joseph Whitner and Despierta, Rise Health is a primary care platform that leverages technology to support providers in taking full financial risk. With a mission to help keep patients healthy, Rise brings proven care delivery and clinical innovations to its patients to ensure they receive the care when, where and how they need it. To learn more about Rise Health’s approach to primary care, visit us at: https://risehealth.net

About Lorient Capital
Lorient is a private investment firm focused exclusively on healthcare service and technology companies. Leveraging its experience as both investors and healthcare operators, Lorient works with founders and management teams to drive growth, optimize operations, and improve healthcare outcomes. Visit us at: https://lorientcap.com/

About Martis Capital
Based in San Francisco, CA and Washington, DC, Martis Capital is a team of investment professionals who share a passion for helping build companies that seek to improve the quality of care and address the complex challenges facing the healthcare industry today. Martis seeks to identify exceptional investment opportunities and achieve shared growth objectives with founder-led companies and management teams. Martis Capital has approximately $2 billion in assets under management and is currently investing out of its fourth fund. Visit us at: https://www.martiscapital.com

About Despierta
Despierta is a Miami-based venture studio that brings healthcare innovations to market faster by partnering with clinical customers at launch. The company is composed of seasoned entrepreneurs and investors passionate about making healthcare more equitable, efficient, and accessible. We centralize care models and include proven tech and scientific innovations in each company we build to better serve patients. To date, the company has launched several businesses across value-based care and science-backed consumer health. Visit us at: https://despierta.vc

 

Contact:
Rise Health Public Relations: info@risehealth.net
Martis Capital Business Development: bd@martiscapital.com

Enter your
text here